THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND
Financial health, per its FY2024 accounts
The accounts state that unrestricted reserves total £7,565,414, which the trustees consider sufficient to maintain operations for three to six months of expenditure. Although the charity reported a net expenditure deficit of £287,641 for the year due to decreased journal income and increased grant spending, it relies on its investment portfolio to replace lost income and sustain its activities.
What the accounts disclose
“It is the policy of the charitable company that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to at least three and six month's expenditure.” — page 9
Structured financials (annual return, FY ending 31/12/2024)
Register events
- Received assets from another charity (23/02/2015)
Trustees
- Prof Mark Johan Arendschair
- Dr Alexander Kieron Haragan
- Dr Emma Louise Short
- Dr Helen Kalirai
- Dr Jennifer Louise Stahle
- Dr Kate Marie Marks
- Dr Kieren Simon James Allinson
- Dr Marnix Jansen
- Dr Matthew Richard Pugh
- Dr Timothy James Kendall
- Honorary Prof Abeer Shaaban
- Prof Gareth Thomas
- Prof John Le Quesne
- Prof Mohammad Ilyas
- Prof Nicholas Paul West
- Prof Richard John Byers
- Professor Sara Ellen Coupland
- Senior Lecturer Tomoko Iwata
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £1.5m | £1.7m |
| 31/12/2023 | £1.0m | £1.8m |
| 31/12/2022 | £1.2m | £961k |
| 31/12/2021 | £1.2m | £1.5m |
| 31/12/2020 | £1.2m | £1.1m |
Common questions
Is THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND financially healthy?
The accounts state that unrestricted reserves total £7,565,414, which the trustees consider sufficient to maintain operations for three to six months of expenditure. Although the charity reported a net expenditure deficit of £287,641 for the year due to decreased journal income and increased grant spending, it relies on its investment portfolio to replace lost income and sustain its activities. Its FY2024 accounts were audited by Xeinadin Audit Limited.